Archive for August 2022

Alpha Cognition Inc., a Bristol Investor Relations client, is a clinical stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, reported financial results and a corporate update for the second quarter ending June 30, 2022.This included positive topline data from the ALPHA-1062 pivotal trial, which allows for the preparation of an…

Viemed Healthcare (a Bristol Investor Relations client) announced that it has reported its financial results for the three and six months ended June 30, 2022. Operational highlights include that net revenues for the quarter were $33.1 million, a new company record. Including COVID-19 related services, total net revenues for the current quarter were $33.3 million.…

Greenbrook TMS, a Bristol Capital client, announced its second quarter 2022 operational and financial results. Some operational and financial highlights: Revenue for Q2 2022 increased by 4% to a record high of $14.2 million. Quarterly treatment volumes increased by 7% to a record high of 62,038 and consultations performed increased by 22. Greenbrook continued the…